EF Stange
Impact in
-
- Inflammatory Bowel Disease
Papers in ⓘ
-
- Liver Diseases and Immunity 3
- Genetics 13
- Inflammatory Bowel Disease 13
- Co-authors
- Klaus Fellermann (6 shared papers)K Herrlinger (6 shared papers)Matthias Schwab (3 shared papers)Klaus Herrlinger (3 shared papers)D Ludwig (4 shared papers)Eike Burmester (2 shared papers)Irmtraut Koop (1 shared paper)H. Koop (1 shared paper)
- Journals
- Journal of Crohn s and Colitis (3 papers)Journal of Lipid Research (3 papers)Gastroenterology (3 papers)Alimentary Pharmacology & Therapeutics (2 papers)Gastrointestinal Endoscopy (1 paper)
- Partner nations
- GermanySwitzerlandSweden
In The Last Decade
EF Stange
31 papers receiving 354 citations
Peers
Comparison fields: 5 of 68
- Transplantation 16
- Genetics 134
- Hepatology 35
- Epidemiology 131
- Gastroenterology 19
Countries citing papers authored by EF Stange
This map shows the geographic impact of EF Stange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by EF Stange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites EF Stange more than expected).
Fields of papers citing papers by EF Stange
This network shows the impact of papers produced by EF Stange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by EF Stange. The network helps show where EF Stange may publish in the future.
Co-authors
The 25 scholars most cited alongside EF Stange, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 42 | |
| 2 | 2011 | 39 | |
| 3 | 2010 | 38 | |
| 4 | 2003 | 37 | |
| 5 | 1998 | 33 | |
| 6 | 2001 | 32 | |
| 7 | 1994 | 23 | |
| 8 | 2010 | 18 | |
| 9 | Updated German Clinical Practice Guideline on "Diagnosis and treatment of Crohn's disease" 2014 AWMF registration no.: 021-004 | 2014 | 17 |
| 10 | 2015 | 13 | |
| 11 | 2009 | 12 | |
| 12 | 1981 | 11 | |
| 13 | 2006 | 7 | |
| 14 | 1992 | 7 | |
| 15 | 2013 | 6 | |
| 16 | 2011 | 5 | |
| 17 | 1990 | 4 | |
| 18 | [Methotrexate therapy of inflammatory diseases. Reliable effects and recent developments in rheumatology, pneumology, gastroenterology and dermatology]. | 1995 | 3 |
| 19 | 1997 | 3 | |
| 20 | [Evidence-based medicine: context and relevance]. | 1999 | 3 |
About EF Stange
EF Stange is a scholar working on Hepatology, Genetics, Epidemiology, Transplantation and Pharmaceutical Science, having authored 34 papers that have together received 368 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (13 papers), Drug Transport and Resistance Mechanisms (6 papers), Microscopic Colitis (4 papers), Autoimmune and Inflammatory Disorders (4 papers), Liver Diseases and Immunity (3 papers), Eosinophilic Esophagitis (3 papers), Drug Solubulity and Delivery Systems (2 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Transplantation (16 citations), Genetics (134 citations), Hepatology (35 citations), Epidemiology (131 citations) and Gastroenterology (19 citations). EF Stange has collaborated with scholars based in Germany, Switzerland and Sweden. Frequent co-authors include Klaus Fellermann, K Herrlinger, Matthias Schwab, Klaus Herrlinger, D Ludwig, Eike Burmester, Irmtraut Koop, H. Koop, Maria Schindler and G. Wiedemann. Their work appears in journals such as Journal of Crohn s and Colitis, Journal of Lipid Research, Gastroenterology, Alimentary Pharmacology & Therapeutics and Gastrointestinal Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.